The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Stealth Coating of Nanoparticles in Drug-Delivery Systems
Open accessAbstract
Nanoparticles (NPs) have emerged as a powerful drug-delivery tool for cancer therapies to enhance the specificity of drug actions, while reducing the systemic side effects. Nonetheless, NPs interact massively with the surrounding physiological environments including plasma proteins upon administration into the bloodstream. Consequently, they are rapidly cleared from the blood circulation by the mononuclear phagocyte system (MPS) or complement system, resulting in a premature elimination that will cause the drug release at off-target sites. By grafting a stealth coating layer onto the surface of NPs, the blood circulation half-life of nanomaterials can be improved by escaping the recognition and clearance of the immune system. This review focuses on the basic concept underlying the stealth behavior of NPs by polymer coating, whereby the fundamental surface coating characteristics such as molecular weight, surface chain density as well as conformations of polymer chains are of utmost importance for efficient protection of NPs. In addition, the most commonly used stealth polymers such as poly(ethylene glycol) (PEG), poly(2-oxazoline) (POx), and poly(zwitterions) in developing long-circulating NPs for drug delivery are also thoroughly discussed. The biomimetic strategies, including the cell-membrane camouflaging technique and CD47 functionalization for the development of stealth nano-delivery systems, are highlighted in this review as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Designing hydrogels for controlled drug delivery
Li, J., & Mooney, D. J. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.71 · Cited by 4,832
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“PEGylated products have emerged in the market for various biomedical applications [47,48].”
BackgroundDrug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“Undoubtedly, the use of therapeutic drugs in clinical applications is often hindered by their intrinsic drawbacks including poor solubility as well as adverse pharmacokinetics and biodistribution [2].”
BackgroundPEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Conformations of Polymers Attached to an Interface
de Gennes, P. G. (1980) · Macromolecules · doi:10.1021/ma60077a009 · Cited by 2,344
Jiang, S., & Cao, Z. (2010) · Advanced Materials · doi:10.1002/adma.200901407 · Cited by 2,027
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Biomimetic materials for tissue engineering
Shin, H., Jo, S., & Mikos, A. G. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00339-9 · Cited by 1,612
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Sarma, J. V., & Ward, P. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1034-0 · Cited by 974
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721 · cited 1×
“In recent years, the increasing concern regarding the use of PEG and its potential immunogenicity has led to a renewed interest towards POx as a promising alternative polymer [62,63].”
BackgroundCancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 702
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Protein adsorption to poly(ethylene oxide) surfaces
Gombotz, W. R., Guanghui, W., Horbett, T. A., & Hoffman, A. S. (1991) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820251211 · Cited by 634
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Surveying for Surfaces that Resist the Adsorption of Proteins
Chapman, R. G., Ostuni, E., Takayama, S., Holmlin, R. E., Yan, L., & Whitesides, G. M. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000774f · Cited by 600
The role of the complement system in cancer
Afshar-Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 554
Lipka, J., Semmler-Behnke, M., Sperling, R. A., Wenk, A., Takenaka, S., Schleh, C., Kissel, T., Parak, W. J., & Kreyling, W. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.009 · Cited by 529
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 503
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
Poly (2-oxazoline) s as polymer therapeutics
Luxenhofer, R., Han, Y., Schulz, A., Tong, J., He, Z., Kabanov, A. V., & Jordan, R. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200354 · Cited by 470
Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes
Gao, W., Hu, C. J., Fang, R. H., Luk, B. T., Su, J., & Zhang, L. (2013) · Advanced Materials · doi:10.1002/adma.201300638 · Cited by 465
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Mero, A., Pasut, G., & Veronese, F. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200049d · Cited by 432
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Kroll, A. V., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00569 · Cited by 379
Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80699-4 · Cited by 369
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Xuan, M., Shao, J., Dai, L., He, Q., & Li, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500129 · Cited by 352
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, Z., Yu, H., Zhang, P., Wang, S., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604300 · Cited by 352
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340
Cao, Z., & Jiang, S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.001 · Cited by 329
Poly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?
Sedlacek, O., Monnery, B. D., Filippov, S. K., Hoogenboom, R., & Hruby, M. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200453 · Cited by 312
Hu, C.-M. J., Fang, R. H., Luk, B. T., Chen, K. N. H., Carpenter, C., Gao, W., Zhang, K., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr00015j · Cited by 308
Applications of viral nanoparticles in medicine
Yildiz, I., Shukla, S., & Steinmetz, N. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.020 · Cited by 299
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery
Kaul, G., & Amiji, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1016486910719 · Cited by 281
Yang, Q., Jones, S. W., Parker, C. L., Zamboni, W. C., Bear, J. E., & Lai, S. K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400703d · Cited by 269
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Zwitteration As an Alternative to PEGylation
Estephan, Z. G., Schlenoff, P. S., & Schlenoff, J. B. (2011) · Langmuir · doi:10.1021/la200227b · Cited by 267
Illum, L., & Davis, S. S. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80836-4 · Cited by 266
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.10.001 · Cited by 263 · cited 1×
“Circulating proteins rapidly adsorb to the surface of NPs, forming a protein corona for various biological events including particle opsonization, phagocytic clearance, formation of immune complexes, and activation or suppression of immune system [23,24].”
BackgroundMoghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90137-e · Cited by 259
Österberg, E., Bergström, K., Holmberg, K., Schuman, T. P., Riggs, J. A., Burns, N. L., Van Alstine, J. M., & Harris, J. M. (1995) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820290610 · Cited by 247
Caracciolo, G. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.11.003 · Cited by 246
Functional groups on polystyrene model nanoparticles: Influence on protein adsorption
Gessner, A., Lieske, A., Paulke, B., & Müller, R. H. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10371 · Cited by 239
Poly(2-oxazoline)s as materials for biomedical applications
de la Rosa, V. R. (2014) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-013-5034-y · Cited by 218
Biology of complement: the overture
Kinoshita, T. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90001-a · Cited by 214
Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.005 · Cited by 209
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Polymers and proteins: interactions at interfaces
Szleifer, I. (1997) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(97)80125-8 · Cited by 207
Cell membrane-covered nanoparticles as biomaterials
Xuan, M., Shao, J., & Li, J. (2019) · National Science Review · doi:10.1093/nsr/nwz037 · Cited by 182
Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics
Vijayan, V., Uthaman, S., & Park, I.-K. (2018) · Polymers · doi:10.3390/polym10090983 · Cited by 178
Moreadith, R. W., Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Rae, B. P., Li, X., et al. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.09.052 · Cited by 177
Engineering Poly(ethylene glycol) Particles for Improved Biodistribution
Cui, J., De Rose, R., Alt, K., Alcantara, S., Paterson, B. M., Liang, K., Hu, M., Richardson, J. J., Yan, Y., Jeffery, C. M., et al. (2015) · ACS Nano · doi:10.1021/nn5061578 · Cited by 170
The CD47-SIRP signalling system: its physiological roles and therapeutic application
Murata, Y., Kotani, T., Ohnishi, H., & Matozaki, T. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu017 · Cited by 169
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
POxylation as an alternative stealth coating for biomedical applications
Bludau, H., Czapar, A. E., Pitek, A. S., Shukla, S., Jordan, R., & Steinmetz, N. F. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.10.041 · Cited by 112 · cited 1×
“[73] investigated the in vivo circulation of the plant viral nanoparticle, tobacco mosaic virus (TMV) conjugated with PMeOx.”
BackgroundEngineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
Yang, H., Shao, R., Huang, H., Wang, X., Rong, Z., & Lin, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2332 · Cited by 112
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Moghimi, S. M., & Davis, S. S. (1994) · PubMed · Cited by 104
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor
Mero, A., Fang, Z., Pasut, G., Veronese, F. M., & Viegas, T. X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.025 · Cited by 95
Carrstensen, H., Müller, R. H., & Müller, B. W. (1992) · Clinical Nutrition · doi:10.1016/0261-5614(92)90006-c · Cited by 95
Stealth coatings for nanoparticles
Hadjesfandiari, N., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00013-1 · Cited by 90
Damodaran, V. B., Fee, C. J., Ruckh, T. T., & Popat, K. C. (2010) · Langmuir · doi:10.1021/la9041502 · Cited by 80
Tong, J., Yi, X., Luxenhofer, R., Banks, W. A., Jordan, R., Zimmerman, M. C., & Kabanov, A. V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300496x · Cited by 80
Cameron, C., Barrett, J. W., Mann, M. J., Lucas, A., & McFadden, G. (2005) · Virology · doi:10.1016/j.virol.2005.03.037 · Cited by 74
Zhao, Y., Wang, C., Wang, L., Yang, Q., Tang, W., She, Z., & Deng, Y. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.023 · Cited by 74
Liu, X., Jin, Q., Ji, Y. C., & Ji, J. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm14178c · Cited by 73
Müller, R. H., Wallis, K. H., Tröster, S. D., & Kreuter, J. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90126-c · Cited by 68
Zhu, Y., Sundaram, H. S., Liu, S., Zhang, L., Xu, X., Yu, Q., Xu, J., & Jiang, S. (2014) · Biomacromolecules · doi:10.1021/bm500209a · Cited by 68
Shalgunov, V., Zaytseva‐Zotova, D., Zintchenko, A., Levada, T., Shilov, Y., Andreyev, D., Dzhumashev, D., Metelkin, E., Urusova, A., Demin, O. O., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.006 · Cited by 66
Ma, Y., Yang, Q., Wang, L., Zhou, X., Zhao, Y., & Deng, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.014 · Cited by 61
Jiang, Z., Tian, Y., Shan, D., Wang, Y., Gerhard, E. M., Xia, J., Huang, R., He, Y., Li, A., Tang, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.002 · Cited by 52
Enhancing blood compatibility of biodegradable polymers by introducing sulfobetaine
Cao, J., Chen, Y., Wang, X., & Luo, X. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33060 · Cited by 42
Nagao, A., Lila, A. S. A., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.015 · Cited by 39
Chen, Q., Ding, H., Zhou, J., Zhao, X., Zhang, J., Yang, C., Li, K., Qiao, M., Hu, H., Ding, P., et al. (2016) · RSC Advances · doi:10.1039/c6ra01580h · Cited by 37
Ishida, T., Maeda, R., Ichihara, M., Mukai, Y., Motoki, Y., Manabe, Y., Irimura, K., & Kiwada, H. (2002) · PubMed · Cited by 35
Dai, Y., Xing, H., Song, F., Yang, Y., Qiu, Z., Lu, X., Liu, Q., Ren, S., Chen, X., & Li, N. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.03.038 · Cited by 35
50 years of poly(2-oxazoline)s
Hoogenboom, R. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2017.01.014 · Cited by 27
Ogawara, K.-I., Yoshida, M., Takakura, Y., Hashida, M., Higaki, K., & Kimura, T. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00116-6 · Cited by 22
Immune-camouflaged graphene oxide nanosheets for negative regulation of phagocytosis by macrophages
Shim, G., Miao, W., Ko, S., Park, G., Kim, J., Kim, M., Kim, Y., & Oh, Y. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00648a · Cited by 18
pH-Triggered copolymer micelles as drug nanocarriers for intracellular delivery
Hao, W., Liu, D., Shang, Y., Zhang, J., Xu, S., & Liu, H. (2016) · RSC Advances · doi:10.1039/c6ra00673f · Cited by 17
Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline)
Fam, S. Y., Chee, C. F., Yong, C. Y., Ho, K. L., Mariatulqabtiah, A. R., Lau, H. Y., & Tan, W. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194903 · Cited by 7
Self-citation
Cited by
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery
Shi, L., Zhang, J., Zhao, M., Tang, S., Cheng, X., Zhang, W., Li, W., Liu, X., Peng, H., & Wang, Q. (2021) · Nanoscale · doi:10.1039/d1nr02065j · Cited by 808
Nanoemulsions for drug delivery
Wilson, R. J., Li, Y., Yang, G., & Zhao, C.-X. (2022) · Particuology · doi:10.1016/j.partic.2021.05.009 · Cited by 367
Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake
Sabourian, P., Yazdani, G., Ashraf, S. S., Frounchi, M., Mashayekhan, S., Kiani, S., & Kakkar, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218019 · Cited by 329
Frontiers in the treatment of glioblastoma: Past, present and emerging
Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.012 · Cited by 257
Metadata
- Authors
- Fam, S. Y., Chee, C. F., Yong, C. Y., Ho, K. L., Mariatulqabtiah, A. R., & Tan, W. S.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2020-04-20
- Volume
- 10
- Issue
- 4
- Pages
- 787
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W3017028564
- Cited by
- 422
- References
- 109
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.